跳至主要内容
临床试验/CTIS2023-503411-15-00
CTIS2023-503411-15-00招募中1 期

A randomized trial investigating the superiority of TDM-optimized teicoplanin dosing versus standard of care - 113998

Stichting Radboud University Medical Center0 个研究点目标入组 74 人开始时间: 2023年3月22日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • 1.The patient is admitted to the ICU, haematology, MDL or orthopaedics department., 2.The patient is at least 18 years old on the day of inclusion., 3.The patient is treated with teicoplanin as part of standard care., 4.The patient or a representative is willing to sign the Informed Consent Form.

排除标准

  • 1. The patient has previously participated in this study., 2.The patient receives any form of RRT other than CVVHD / CVVHDF., 3.Expected duration of teicoplanin therapy is less than 5 days., Pregnant individuals

研究者

发起方
Stichting Radboud University Medical Center

相似试验